Evidence map›Paper›PMID 33682470›Full record

ArticleAnnals of the Royal College of Surgeons of England2021

The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.

L Irace, O Martinelli, R Gattuso, A Mingoli, E Fiori, A Alunno, A Di Girolamo, D Crocetti, P Sapienza

Abstract read
In one paragraph

Article in Annals of the Royal College of Surgeons of England, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Lung cancer invading the superior vena cava - surgical treatment. A short and up-to-date review.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2023
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

L IraceSapienza University of Rome, Italy.
O MartinelliSapienza University of Rome, Italy.
R GattusoSapienza University of Rome, Italy.
A MingoliSapienza University of Rome, Italy.
E FioriSapienza University of Rome, Italy.
A AlunnoSapienza University of Rome, Italy.
A Di GirolamoSapienza University of Rome, Italy.
D CrocettiSapienza University of Rome, Italy.
P SapienzaSapienza University of Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSuperior vena cava (SVC) syndrome (SVCS) is a life-threatening occurrence that necessitates prompt treatment. At present, endovascular stenting is proposed as a first-line treatment to relieve symptoms. We assessed the effectiveness, safety and outcome of SVC stent positioning in patients affected with advanced cancer.

methodsForty-two patients undergoing stent positioning in the SVC for neoplasms from January 2002 to December 2018 form the basis of this retrospective study. Demographic data, risk factors, associated diseases, symptoms at presentation according to the score proposed by Kishi and the type of SVCS according to Sanford and Doty were collected. Minor and major complications were recorded. Suspected stent occlusion was confirmed by means of recurrence of symptoms followed by a confirmatory computed tomography (CT).

resultsThirty-four (81%) patients had a nonresectable lung tumour invading or compressing the SVC. Five (12%) patients had a non-Hodgkin's lymphoma, and three (7%) had metastatic lymphadenopathies. Nitinol stents (Memotherm

conclusionsWe recommend the use of the endovascular procedure as a first-line treatment in locally advanced or metastatic tumour in the presence of SVCS.

Indexed as

Self Expandable Metallic StentsAdultAgedAged, 80 and overCarcinomaEndovascular ProceduresFemaleFollow-Up StudiesHumansKaplan-Meier EstimateLung NeoplasmsLymphatic MetastasisLymphoma, Non-HodgkinMaleMiddle AgedRetrospective StudiesLung cancerNon-Hodgkin’s lymphomaSuperior vena cava self-expanding stentSuperior vena cava syndrome

Identifiers

PMID33682470
PMCPMC10335251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.